Home Applications 209354 Application 209354
Type NDA
Sponsor BAUSCH Application Products# Product, Drug, Ingredient table Product Drug Ingredient Form Strength Reference drug Reference standard 001 DUOBRII HALOBETASOL PROPIONATE; TAZAROTENE LOTION;TOPICAL 0.01%;0.045% Yes Yes
Source provenance: Browse the complete Orange Book source catalog · source snapshot 42 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date N209354-001 DUOBRII HALOBETASOL PROPIONATE; TAZAROTENE 0.01%;0.045% LOTION / TOPICAL AB RLD, RS 2019-04-25
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code N209354-001 AB
Orange Book patents# Current patent rows page 1 of 1 · 10 matching rows.
Application-product, Patent, Expiration table Application-product Patent Expiration Use code Coverage / status Submission date N209354-001 10478502 2031-11-02 U-2625 Drug product 2019-11-22 N209354-001 11839656 2031-11-02 U-2625 2024-01-05 N209354-001 11957753 2031-11-02 Drug product 2024-05-10 N209354-001 11986527 2031-11-02 U-2625 2024-06-13 N209354-001 12076403 2031-11-02 Drug product 2024-09-24 N209354-001 8809307 2031-11-02 Drug product 2019-04-30 N209354-001 10251895 2036-06-06 Drug product 2019-04-26 N209354-001 10426787 2036-06-06 U-2625 2019-10-09 N209354-001 11648256 2036-06-06 U-2625 Drug product 2023-06-13 N209354-001 11679115 2036-06-06 U-2625 Drug product 2023-07-13
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Product history page 1 of 2 · 42 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-08-18 06:07:40 2026-07 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL AB RLD, RS 2019-04-25 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL AB RLD, RS 2019-04-25 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL AB RLD, RS 2019-04-25 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL AB RLD, RS 2019-04-25 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 8072bd15b7f6…2022-06-29 02:47 UTC · 2 captures of this ZIP 2022-06 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 5c6f7cd8ea54…2022-04-08 23:34 UTC 2022-04 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 5d02ea3f76ae…2022-04-04 05:41 UTC 2022-04 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 4b0b4de00fa7…2019-12-13 00:20 UTC 2019-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 74a2ff9319b5…2022-03-09 01:35 UTC 2022-03 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 bb7c543d1eb4…2021-12-28 21:50 UTC 2021-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 782e0a99824c…2021-05-05 16:15 UTC · 3 captures of this ZIP 2021-05 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 87673890dc5c…2021-03-12 10:30 UTC 2021-03 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 5aa47cf7b7d7…2020-12-22 03:56 UTC 2020-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 8869cabd3fbd…2020-11-12 02:37 UTC 2020-11 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 c0c555d07b60…2019-12-14 00:12 UTC 2019-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 3f01610625f2…2019-09-15 20:21 UTC 2019-09 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 b00525d2431f…2019-07-19 19:46 UTC 2019-07 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 ea99ee380514…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 053a50430f4f…2023-01-26 05:58 UTC 2023-01 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 N209354-001 DUOBRII 0.01%;0.045% LOTION / TOPICAL RLD, RS 2019-04-25 e64feba35796…
Observed Orange Book normalized TE history# Observed Orange Book patent history# Patent history page 1 of 7 · 271 observed states.
Captured, Edition, Application-product table Captured Edition Application-product Patent Expiration Use code Coverage / status Submission date Source SHA-256 2026-08-18 06:07:40 2026-07 N209354-001 10478502 2031-11-02 U-2625 Drug product 2019-11-22 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 11839656 2031-11-02 U-2625 2024-01-05 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 11957753 2031-11-02 Drug product 2024-05-10 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 11986527 2031-11-02 U-2625 2024-06-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 12076403 2031-11-02 Drug product 2024-09-24 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 8809307 2031-11-02 Drug product 2019-04-30 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 10251895 2036-06-06 Drug product 2019-04-26 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 10426787 2036-06-06 U-2625 2019-10-09 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 11648256 2036-06-06 U-2625 Drug product 2023-06-13 caaa826d4ba7…2026-08-18 06:07:40 2026-07 N209354-001 11679115 2036-06-06 U-2625 Drug product 2023-07-13 caaa826d4ba7…2026-02-19 14:30 UTC 2026-02 N209354-001 10478502 2031-11-02 U-2625 Drug product 2019-11-22 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 11839656 2031-11-02 U-2625 2024-01-05 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 11957753 2031-11-02 Drug product 2024-05-10 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 11986527 2031-11-02 U-2625 2024-06-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 12076403 2031-11-02 Drug product 2024-09-24 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 8809307 2031-11-02 Drug product 2019-04-30 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 10251895 2036-06-06 Drug product 2019-04-26 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 10426787 2036-06-06 U-2625 2019-10-09 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 11648256 2036-06-06 U-2625 Drug product 2023-06-13 011fe1cb6892…2026-02-19 14:30 UTC 2026-02 N209354-001 11679115 2036-06-06 U-2625 Drug product 2023-07-13 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 10478502 2031-11-02 U-2625 Drug product 2019-11-22 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 11839656 2031-11-02 U-2625 2024-01-05 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 11957753 2031-11-02 Drug product 2024-05-10 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 11986527 2031-11-02 U-2625 2024-06-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 12076403 2031-11-02 Drug product 2024-09-24 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 8809307 2031-11-02 Drug product 2019-04-30 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 10251895 2036-06-06 Drug product 2019-04-26 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 10426787 2036-06-06 U-2625 2019-10-09 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 11648256 2036-06-06 U-2625 Drug product 2023-06-13 31067a03dcf5…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 N209354-001 11679115 2036-06-06 U-2625 Drug product 2023-07-13 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 N209354-001 10478502 2031-11-02 U-2625 Drug product 2019-11-22 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 11839656 2031-11-02 U-2625 2024-01-05 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 11957753 2031-11-02 Drug product 2024-05-10 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 11986527 2031-11-02 U-2625 2024-06-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 12076403 2031-11-02 Drug product 2024-09-24 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 8809307 2031-11-02 Drug product 2019-04-30 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 10251895 2036-06-06 Drug product 2019-04-26 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 10426787 2036-06-06 U-2625 2019-10-09 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 11648256 2036-06-06 U-2625 Drug product 2023-06-13 6a471c1ec25d…2025-08-23 18:47 UTC 2025-08 N209354-001 11679115 2036-06-06 U-2625 Drug product 2023-07-13 6a471c1ec25d…
Observed Orange Book exclusivity history# openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 1 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Duobrii HALOBETASOL PROPIONATE AND TAZAROTENE Bausch Health US, LLC b3f0cdc0-69fd-43d1-baf2-d776a3a20715 2020-01-01 Warnings, Adverse reactions Exact identifier application applno (NDA): 209354 application number: NDA209354 ndc (product): 0187-0653
NDC Listings For This Application# NDC listings for this application page 1 of 1 · 4 matching rows.
NDC, Name, Nonproprietary name table NDC Name Nonproprietary name Labeler Marketing category Status 0187-0653 Duobrii halobetasol propionate and tazarotene Bausch Health US, LLC NDA Current 0187-0653 Duobrii halobetasol propionate and tazarotene Bausch Health US, LLC NDA Current 0187-0653 Duobrii halobetasol propionate and tazarotene Bausch Health US, LLC NDA Current 0187-0653 Duobrii halobetasol propionate and tazarotene Valeant Pharmaceuticals North America LLC NDA Current
Documents# Document, Submission type, Date table Document Submission type Date 61551 ORIG 2020-01-10 58456 ORIG 2019-04-29 58442 ORIG 2019-04-26